VivoSim Labs (VIVS) Current Assets (2011 - 2026)
VivoSim Labs (VIVS) posted quarterly Current Assets of $6.6 million for Q1 2026, down 45.59% year-over-year from $12.1 million in Q1 2025, and up 9.25% quarter-over-quarter from $6.0 million in Q4 2025.
VivoSim Labs (VIVS) Current Assets (2011 - 2026) Analysis & Trends
VivoSim Labs' Current Assets history runs 16 years deep, the most recent figure standing at $6.6 million for Q1 2026.
- In Q1 2026, Current Assets fell 45.59% year-over-year to $6.6 million; the TTM figure through Mar 2026 stood at $6.6 million (down 45.59% YoY), while the FY2026 annual figure was $6.6 million, down 45.59% from the prior year.
- Current Assets for Q1 2026 stood at $6.6 million, up from $6.0 million in the prior quarter.
- The five-year high for Current Assets was $29.5 million in Q1 2022, with the low at $2.1 million in Q4 2024.
- The 5-year median for Current Assets is $8.3 million (2023), against an average of $12.1 million.
- The sharpest annual moves came in 2024 and 2025: Current Assets slumped 76.91% in 2024, then jumped 208.21% in 2025.
- VivoSim Labs' Current Assets stood at $21.6 million in 2022, then plunged by 71.13% to $6.2 million in 2023, then slumped by 66.35% to $2.1 million in 2024, then jumped by 187.67% to $6.0 million in 2025, then gained by 9.25% to $6.6 million in 2026.
- Business Quant data shows VIVS's Current Assets at $6.6 million in Q1 2026, $6.0 million in Q4 2025, and $7.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 1.76 Bn |
| 10 | VivoSim Labs | 1.44 Mn | 1.44 Mn | - | 3.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.23 Mn |
| Mar 31, 2026 | 6.60 Mn |
| Dec 31, 2025 | 6.04 Mn |
| Sep 30, 2025 | 7.59 Mn |
| Jun 30, 2025 | 9.68 Mn |
| Mar 31, 2025 | 12.13 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Sep 30, 2024 | 4.78 Mn |
| Jun 30, 2024 | 7.28 Mn |
| Mar 31, 2024 | 3.94 Mn |
| Dec 31, 2023 | 6.24 Mn |
| Sep 30, 2023 | 8.30 Mn |
| Jun 30, 2023 | 11.70 Mn |
| Mar 31, 2023 | 17.05 Mn |
| Dec 31, 2022 | 21.61 Mn |
| Sep 30, 2022 | 24.36 Mn |
| Jun 30, 2022 | 26.91 Mn |
| Mar 31, 2022 | 29.53 Mn |
| Dec 31, 2021 | 31.17 Mn |
| Sep 30, 2021 | 34.30 Mn |